Top Markets
Coin of the day
CARGO Therapeutics, Inc. Common Stock CARGO Therapeutics, Inc. Common Stock

CARGO Therapeutics, Inc. Common Stock

CRGX
Rang in aandelen #18093
CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company... CARGO Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to pioneering innovative chimeric antigen receptor (CAR) T-cell therapies for patients battling cancer. Its primary therapeutic candidate is CRG-022, an autologous CD22 CAR T-cell product. This therapy is specifically engineered to counteract mechanisms of resistance in B-cell malignancies by targeting CD22, a distinct tumor antigen prevalent in these conditions. The company's pipeline also includes CRG-023, a novel tri-specific CAR T product candidate designed to engage tumor cells through three different B-cell antigen targets. Formerly known as Syncopation Life Sciences, Inc., the company adopted its current name, CARGO Therapeutics, Inc., in September 2022. Established in 2019, CARGO Therapeutics is headquartered in San Mateo, California.
Aandeelprijs
$4.47
Laatst gesynchroniseerd: 2025-08-20
Marktkapitalisatie
$213.06M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel CARGO Therapeutics, Inc. Common Stock (CRGX)

Categorie

Koersgeschiedenis voor CARGO Therapeutics, Inc. Common Stock (CRGX)
Hoogste slotkoers: $4.48 op 2025-08-01

Laagste slotkoers: $14.85 op 2023-11-01
Koersgeschiedenis van CARGO Therapeutics, Inc. Common Stock van 2023 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2025 -71.01%
2024 -16.24%
2023 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.66 -9.24%
AU
$757.71 6.76%
CH